Sorry, you need to enable JavaScript to visit this website.

Contact Us / Email

Please use the form below. Your message is important to us and will be reviewed by the appropriate team within Pfizer.

Please note that this form is for submitting partnering opportunities to Pfizer’s business development group. This form should not be used for reporting adverse events, submitting resumes, seeking vendor or supplier contacts, etc. There are other areas of the www.pfizer.com website that should be used for each of these specific topics. Thank you for your understanding.

Required

- Select -
- Select -
Partnering Ideas Form
- Select -
- Select -
Academic Partnerships
Hospital
Inflammation & Immunology
Internal Medicine
Oncology
Rare Disease
Vaccines
Out-Licensing
Manufacturing & Supply Partnering
Pfizer Ventures

Limit 500 characters

By submitting this proposal to Pfizer, I represent and warrant that I have the authority to disclose this information to Pfizer.  I acknowledge that I make this submission voluntarily.  I agree that no relationship is established or implied by Pfizer’s acceptance or evaluation of the submitted material, and that Pfizer shall have the right to retain this proposal and submitted material if it chooses to do so.  Pfizer shall not be obligated to specify the reasons for any decision it makes regarding the idea or to reveal any past or present activities that relate to the idea. 

CAPTCHA

This form is for submitting partnering opportunities to our business development group only.

We read all messages. However, you may not receive a personal reply due to the large volume of messages we receive.

Areas of Inquiry

  • - Select -
    - Select -
    Shareholder Services
    General Company Information
    Patient Assistance
    Privacy Officer
    Web Site Feedback
    500 character(s) remaining
    - Select -
    - Select -
    Afghanistan
    Albania
    Algeria
    American Samoa
    Andorra
    Angola
    Anguilla
    Antarctica
    Antigua and Barbuda
    Argentina
    Armenia
    Aruba
    Australia
    Austria
    Azerbaijan
    Bahamas
    Bahrain
    Bangladesh
    Barbados
    Belarus
    Belgium
    Belize
    Benin
    Bermuda
    Bhutan
    Bolivia
    Bosnia and Herzegovina
    Botswana
    Bouvet Island
    Brazil
    British Indian Ocean Territory
    Brunei Darussalam
    Bulgaria
    Burkina Faso
    Burundi
    Cambodia
    Cameroon
    Canada
    Cape Verde
    Cayman Islands
    Central African Republic
    Chad
    Chile
    China
    Christmas Island
    Cocos (Keeling) Islands
    Colombia
    Comoros
    Congo
    Congo, The Democratic Republic
    Cook Islands
    Costa Rica
    Cote D'ivoire
    Croatia
    Cuba
    Cyprus
    Czech Republic
    Denmark
    Djibouti
    Dominica
    Dominican Republic
    East Timor
    Ecuador
    Egypt
    El Salvador
    Equatorial Guinea
    Eritrea
    Estonia
    Ethiopia
    Falkland Islands (Malvinas)
    Faroe Islands
    Fiji
    Finland
    France
    France, Metropolitan
    French Guiana
    French Polynesia
    French Southern Territories
    Gabon
    Gambia
    Georgia
    Germany
    Ghana
    Gibraltar
    Greece
    Greenland
    Grenada
    Guadeloupe
    Guam
    Guatemala
    Guinea
    Guinea-bissau
    Guyana
    Haiti
    Heard and Mc Donald Islands
    Holy See (Vatican City State)
    Honduras
    Hong Kong
    Hungary
    Iceland
    India
    Indonesia
    Iran (Islamic Republic of)
    Iraq
    Ireland
    Israel
    Italy
    Jamaica
    Japan
    Jordan
    Kazakhstan
    Kenya
    Kiribati
    Korea
    Korea, Democratic People's Rep
    Kosovo
    Kuwait
    Kyrgyzstan
    Lao People's Democratic Republ
    Latvia
    Lebanon
    Lesotho
    Liberia
    Libyan Arab Jamahiriya
    Liechtenstein
    Lithuania
    Luxembourg
    Macau
    Macedonia, The Former Yugoslav
    Madagascar
    Malawi
    Malaysia
    Maldives
    Mali
    Malta
    Marshall Islands
    Martinique
    Mauritania
    Mauritius
    Mayotte
    Mexico
    Micronesia, Federated States o
    Moldova, Republic of
    Monaco
    Mongolia
    Montenegro
    Montserrat
    Morocco
    Mozambique
    Myanmar
    Namibia
    Nauru
    Nepal
    Netherlands
    Netherlands Antilles
    New Caledonia
    New Zealand
    Nicaragua
    Niger
    Nigeria
    Niue
    Norfolk Island
    Northern Mariana Islands
    Norway
    Oman
    Pakistan
    Palau
    Panama
    Papua New Guinea
    Paraguay
    Peru
    Philippines
    Pitcairn
    Poland
    Portugal
    Puerto Rico
    Qatar
    Reunion
    Romania
    Russia
    Russian Federation
    Rwanda
    Saint Kitts and Nevis
    Saint Lucia
    Saint Vincent and the Grenadin
    Samoa
    San Marino
    Sao Tome and Principe
    Saudi Arabia
    Senegal
    Serbia
    Seychelles
    Sierra Leone
    Singapore
    Slovakia (Slovak Republic)
    Slovenia
    Solomon Islands
    Somalia
    South Africa
    South Georgia and the South Sa
    Spain
    Sri Lanka
    St. Helena
    St. Pierre and Miquelon
    Sudan
    Suriname
    Svalbard and Jan Mayen Islands
    Swaziland
    Sweden
    Switzerland
    Syrian Arab Republic
    Taiwan
    Tajikistan
    Tanzania, United Republic of
    Thailand
    Togo
    Tokelau
    Tonga
    Trinidad and Tobago
    Tunisia
    Turkey
    Turkmenistan
    Turks and Caicos Islands
    Tuvalu
    USA
    Uganda
    Ukraine
    United Arab Emirates
    United Kingdom
    United States Minor Outlying I
    Uruguay
    Uzbekistan
    Vanuatu
    Venezuela
    Vietnam
    Virgin Islands (British)
    Virgin Islands (U.S.)
    Wallis and Futuna Islands
    Western Sahara
    Yemen
    Zambia
    Zimbabwe
    - None -
    - None -
    Job Seeker
    Shareholder
    Press/Media
    Consumer
    Student
    Financial Analyst
    Healthcare Professional
    Supplier
    Pharmacist
    Other

    By providing your email address, you agree to receive an email response from Pfizer to your inquiry. Your email address will only be used to respond to your inquiry. The information you submit will be governed by our Privacy Policy

    CAPTCHA
  • Customer Service and Product Inquiries:
    1-800-TRY-FIRST (1-800-879-3477)
    Monday through Friday 9:00 a.m. to 7:00 p.m. EST

    Corporate Office:
    (212) 733-2323
    66 Hudson Boulevard East, New York, NY 10001-2192

    Professional members of the media should visit our

    News & Media Contact Information

    To contact one of our country offices, please visit the specific country Web sites for contact information. Go to our complete index of Pfizer country Web sites.

FAQ: Get an Answer Right Away

Have a question? There's a good chance the answer is right here.

Please take a look at our Frequently Asked Questions before contacting us directly. The answer to your question may actually be just a click away.

Find Answers in our FAQ Details

Adverse Events

You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food & Drug Administration (FDA) directly.

The FDA has established a reporting service known as MedWatch through which healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch at www.fda.gov/Safety/MedWatchextlink label or call 1-800-FDA-1088.

Outside the United States

Countries worldwide may have specific processes in place to handle reports of adverse events. To report an adverse event, ask your health care provider for more information or contact your local health authority.

To learn more about medicine safety, visit our Medicine Safety page.

Go to Medicine Safety Details